FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a method of preparing a compound of formula
or its tautomer, stereoisomer, or pharmaceutically acceptable salt, consisting in the fact that: (a) compound of formula
is introduced into a reaction with a compound of formula
to produce a compound of formula
, where Q means NO2; one of L1 or L2 means halogen, and the other of L1 or L2 means OH or its anion; Z means a cyano group or COOR5 where R5 means hydrogen or a hydroxy-protecting group; (b) when in the compound of formula (IV), Z means a cyano group or COOR5, said compound is transformed into the compound of formula (IV) where Z means CHO; (c) when in the compound of formula (IV) Z means CHO, said compound is introduced into a reaction with a compound of formula
to produce a compound of formula (VI) where R4p and R4q in formula (Vb) mean independently H or C1-6alkyl provided at least one of R4p and R4q means C1-6alkyl, and Xb means =O or =NHOH; (d) when in the compound of formula
Q means NO2, said compound is transformed into the compound of formula (VI) where Q means NH2; (e) the compound of formula (VI) where Q means NH2 is introduced into a reaction with a compound of formula
to produce the compound of formula (VIII) or its tautomer; (f) a compound of formula
or its tautomer is introduced into a reaction with a desulphating agent to produce the compound of formula (I); (g) optionally, the compound of formula (I) or its tautomer is introduced into a reaction with an to produce a first pharmaceutically acceptable salt; (h) optionally, the first pharmaceutically acceptable salt of the compound of formula (I) or its tautomer is transformed into a second pharmaceutically acceptable salt. Also, the invention refers to alternative methods of producing the compound of formula I.
EFFECT: new improved methods of producing the compound of formula I are implemented.
19 cl, 1 tbl, 82 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2401265C2 |
IMMUNOSUPPRESSIVE COMPOUNDS AND COMPOSITIONS | 2004 |
|
RU2405768C2 |
NOVEL VINYLOGENIC ACID DERIVATIVES | 2006 |
|
RU2425830C2 |
COMPOUNDS AND COMPOSITIONS AS CANNABINOID RECEPTOR 1 INHIBITORS | 2005 |
|
RU2431635C2 |
NEW COMPOUNDS | 2007 |
|
RU2456273C2 |
COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS | 2008 |
|
RU2443699C2 |
COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
CONDENSED DERIVATIVES OF AZOLPYRIMINE WITH INHIBITING PROPERTIES OF PHOSPHATIDYL INOSITOL-3-KINASE (PI3K) | 2003 |
|
RU2326881C9 |
HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2010 |
|
RU2558141C2 |
PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS | 2004 |
|
RU2419612C2 |
Authors
Dates
2011-07-27—Published
2006-08-30—Filed